The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Delgado, M.
Right arrow Articles by Ganea, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Delgado, M.
Right arrow Articles by Ganea, D.
The Journal of Immunology, 1999, 163: 4213-4223.
Copyright © 1999 by The American Association of Immunologists

VIP and PACAP Differentially Regulate the Costimulatory Activity of Resting and Activated Macrophages Through the Modulation of B7.1 and B7.2 Expression1

Mario Delgado*,{dagger}, Wei Sun*, Javier Leceta{dagger} and Doina Ganea2,*

* Department of Biological Sciences, Rutgers University, Newark, NJ 07102; and {dagger} Departamento Biologia Celular, Universidad Complutense, Madrid, Spain

Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase activating polypeptide (PACAP), two structurally related neuropeptides produced and/or released within the lymphoid microenvironment, modulate numerous immune functions. Although primarily antiinflammatory in nature, VIP and PACAP also affect resting macrophages. In this study, we report on in vitro and in vivo dual effects of VIP/PACAP on the expression of B7.1 and B7.2 and on the costimulatory activity for T cells in unstimulated and LPS/IFN-{gamma}-activated macrophages. VIP and PACAP up-regulate B7.2, but not B7.1, expression and induce the capacity to stimulate the proliferation of naive T cells in response to soluble anti-CD3 or allogeneic stimulation. In contrast, both neuropeptides down-regulate B7.1/B7.2 expression on LPS/IFN-{gamma}-activated macrophages and inhibit the endotoxin-induced costimulatory activity for T cells. Interestingly, both the stimulatory and the inhibitory effects of VIP/PACAP are mediated through the specific receptor VPAC1 and involve the cAMP/protein kinase A transduction pathway. The dual effect on B7.1 and B7.2 expression occurs at both mRNA and protein level and correlates with the VIP/PACAP regulation of the macrophage costimulatory activity. Through their regulatory role for resting and activated macrophages, VIP and PACAP act as endogenous participants in the control of immune homeostasis. Their effects depend not only on the timing of their release, but also on the activation and differentiation state of the neighboring immune cells.




This article has been cited by other articles:


Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
C. W. Michalski, F. Selvaggi, M. Bartel, T. Mitkus, A. Gorbachevski, T. Giese, P. D. Sebastiano, N. A. Giese, and H. Friess
Altered anti-inflammatory response of mononuclear cells to neuropeptide PACAP is associated with deregulation of NF-{kappa}B in chronic pancreatitis
Am J Physiol Gastrointest Liver Physiol, January 1, 2008; 294(1): G50 - G57.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
D. Fabricius, M. S. O'Dorisio, S. Blackwell, and B. Jahrsdorfer
Human Plasmacytoid Dendritic Cell Function: Inhibition of IFN-{alpha} Secretion and Modulation of Immune Phenotype by Vasoactive Intestinal Peptide
J. Immunol., November 1, 2006; 177(9): 5920 - 5927.
[Abstract] [Full Text] [PDF]

Home page
 Mult SclerHome page
H. Kato, A. Ito, J. Kawanokuchi, S. Jin, T. Mizuno, K. Ojika, R. Ueda, and A. Suzumura
Pituitary adenylate cyclase-activating polypeptide (PACAP) ameliorates experimental autoimmune encephalomyelitis by suppressing the functions of antigen presenting cells
Multiple Sclerosis, December 1, 2004; 10(6): 651 - 659.
[Abstract] [PDF]

Home page
 J. Immunol.Home page
S. Kodali, W. Ding, J. Huang, K. Seiffert, J. A. Wagner, and R. D. Granstein
Vasoactive Intestinal Peptide Modulates Langerhans Cell Immune Function
J. Immunol., November 15, 2004; 173(10): 6082 - 6088.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
M. Delgado, D. Pozo, and D. Ganea
The Significance of Vasoactive Intestinal Peptide in Immunomodulation
Pharmacol. Rev., June 1, 2004; 56(2): 249 - 290.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
M. Delgado, A. Reduta, V. Sharma, and D. Ganea
VIP/PACAP oppositely affects immature and mature dendritic cell expression of CD80/CD86 and the stimulatory activity for CD4+ T cells
J. Leukoc. Biol., June 1, 2004; 75(6): 1122 - 1130.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. C. Grimm, R. Newman, Z. Hassim, N. Cuan, S. J. Connor, Y. Le, J. M. Wang, J. J. Oppenheim, and A. R. Lloyd
Cutting Edge: Vasoactive Intestinal Peptide Acts as a Potent Suppressor of Inflammation In Vivo by Trans-Deactivating Chemokine Receptors
J. Immunol., November 15, 2003; 171(10): 4990 - 4994.
[Abstract] [Full Text] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
M. DELGADO, C. ABAD, C. MARTINEZ, M. G. JUARRANZ, J. LECETA, D. GANEA, and R. P. GOMARIZ
PACAP in Immunity and Inflammation
Ann. N.Y. Acad. Sci., May 1, 2003; 992(1): 141 - 157.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
K. G. Brinker, H. Garner, and J. R. Wright
Surfactant protein A modulates the differentiation of murine bone marrow-derived dendritic cells
Am J Physiol Lung Cell Mol Physiol, January 1, 2003; 284(1): L232 - L241.
[Abstract] [Full Text] [PDF]

Home page
 Crit. Rev. Oral Biol. Med.Home page
D. Ganea and M. Delgado
VASOACTIVE INTESTINAL PEPTIDE (VIP) AND PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE (PACAP) AS MODULATORS OF BOTH INNATE AND ADAPTIVE IMMUNITY
Crit. Rev. Oral. Biol. Med., May 1, 2002; 13(3): 229 - 237.
[Abstract] [Full Text]

Home page
 J. Immunol.Home page
E. Kuroda, T. Sugiura, K. Okada, K. Zeki, and U. Yamashita
Prostaglandin E2 Up-Regulates Macrophage-Derived Chemokine Production but Suppresses IFN-Inducible Protein-10 Production by APC
J. Immunol., February 1, 2001; 166(3): 1650 - 1658.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. Delgado and D. Ganea
Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase-Activating Polypeptide Inhibit Expression of Fas Ligand in Activated T Lymphocytes by Regulating c-Myc, NF-{{kappa}}B, NF-AT, and Early Growth Factors 2/3
J. Immunol., January 15, 2001; 166(2): 1028 - 1040.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
I. J. Elenkov, R. L. Wilder, G. P. Chrousos, and E. S. Vizi
The Sympathetic Nerve---An Integrative Interface between Two Supersystems: The Brain and the Immune System
Pharmacol. Rev., December 1, 2000; 52(4): 595 - 638.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
D. Vaudry, B. J. Gonzalez, M. Basille, L. Yon, A. Fournier, and H. Vaudry
Pituitary Adenylate Cyclase-Activating Polypeptide and Its Receptors: From Structure to Functions
Pharmacol. Rev., June 1, 2000; 52(2): 269 - 324.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. Delgado and D. Ganea
Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase-Activating Polypeptide Inhibit Antigen-Induced Apoptosis of Mature T Lymphocytes by Inhibiting Fas Ligand Expression
J. Immunol., February 1, 2000; 164(3): 1200 - 1210.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Delgado and D. Ganea
Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase-activating Polypeptide Inhibit Nuclear Factor-kappa B-dependent Gene Activation at Multiple Levels in the Human Monocytic Cell Line THP-1
J. Biol. Chem., January 5, 2001; 276(1): 369 - 380.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.